Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Tri Locum Partners LP
Form 13F · Q2 2026

Tri Locum Partners LP

CIK 1826434申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$8.1亿
申報組合市值
19
持倉數量
12
Quarters on record
Top 50
持倉數量

Tri Locum Partners LP——持倉

共 19 個持倉中的前 19 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1JNJ Johnson & Johnson424,945+2.5%$1.1亿13.3%
2VRTX Vertex Pharmaceuticals Inc201,791+56.0%$1.0亿12.3%
3LLY Eli Lilly & Co76,532+23.8%$9179万11.3%
4ASND Ascendis Pharma A/S258,740—$6901万8.5%
5DXCM Dexcom Inc820,479+17.5%$5526万6.8%
6AXSM Axsome Therapeutics Inc.219,308+253.1%$5368万6.6%
7JAZZ Jazz Pharmaceuticals Plc221,720+39.7%$5343万6.6%
8ELVN Enliven Therapeutics Inc866,716—$4399万5.4%
9ARGX Argenx Se41,596+31.5%$3859万4.7%
10MDGL Madrigal Pharmaceuticals Inc68,273−33.9%$3666万4.5%
11RVMD Revolution Medicines Inc151,822—$2843万3.5%
12UTHR United Therapeutics Corp Del47,026−33.2%$2548万3.1%
13TEVA Teva Pharmaceutical Inds Ltd746,835−26.9%$2530万3.1%
14TARS Tarsus Pharmaceuticals Inc328,340+30.0%$2067万2.5%
15ISRG Intuitive Surgical Inc47,983−68.7%$1908万2.3%
16CYTK Cytokinetics Inc194,000—$1653万2.0%
17DNTH Dianthus Therapeutics Inc120,712−17.1%$1177万1.4%
18BBNX Beta Bionics Inc493,344—$773万1.0%
19DFTX Definium Therapeutics Inc162,996−55.9%$767万0.9%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。